Platelet Rich Plasma Injections
The use of autologous platelet rich plasma injections for conditions such as tendinopathy, early articular cartilage wear, and as an augment treatment for meniscal tear surgery has grown in popularity in the last five years.
There is debate in the scientific literature about its efficacy.
The National Institute for Health and Care Excellence (NICE) has recently approved the use of PRP injections for the treatment of early stage osteoarthritis of the knee (but if used it must be registered as part of a clinical audit or trial so that the outcome of the injection is recorded). Further information is available at the NICE website.